Intelligence Platform
Patents
Browse 565 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9585975
MRI contrast agents
granted patentUS 9586890
Screening methods for the binding affinity of chemical entities to biological molecules an
granted patentUS 9580400
Cannabinergic nitrate esters and related analogs
granted patentUS 9572910
pH responsive self-healing hydrogels formed by boronate-catechol complexation
granted patentUS 9566355
Bacteria-targeted magnetic resonance contrast agents
granted patentUS 9556232
Anti-angiogenic molecules, nanostructures and uses thereof
granted patentUS 9533947
Benzamide compounds and related methods of use
granted patentUS 9532948
Nanostructure suitable for sequestering cholesterol and other molecules
granted patentUS 9527819
Pyridazine compounds, compositions and methods
granted patentUS 9522180
Peptide conjugated particles
granted patentUS 9517233
Local cochlear application of statins for stimulating neurite regrowth in the cochlea
granted patentUS 9517275
Targeted therapy for the prevention of restenosis in the cardiovascular system
granted patentUS 9512133
NMDA receptor modulators and uses thereof
granted patentUS 9506056
Nucleic acid functionalized nanoparticles for therapeutic applications
granted patentUS 9499494
Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
granted patentUS 9486540
Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat
granted patentUS 9474716
SiRNA phospholipid conjugate
granted patentUS 9463186
Treatment for dopaminergic disorders
granted patentUS 9428467
Selective calcium channel antagonists
granted patentUS 9408845
Formulations containing pyridazine compounds
granted patentUS 9376690
Templated nanoconjugates
granted patentUS 9371277
Benzamide compounds and related methods of use
granted patentUS 9340576
Methods of treating depression and other related diseases
granted patentUS 9340792
Recombinant Lactobacillus with decreased lipoteichoic acid to reduce inflammatory response
granted